Article Summary, Automatically Generated By AI
Summary of CDbio
- CDBIO is a medical foundation based in the Republic of Seychelles.
- CEO: Yasama Yasuhiko, also CTO of CDBIO Foundation and researcher at Tohoku Univ Research and Analytical Center.
- Technology: Molecular sensors using lithium-resistant fullerene for high-precision diagnosis and health monitoring.
- Goal: Create a blockchain healthcare ecosystem combining molecular physics and medical expertise for personalized medicine.
- Aim: Overcome diseases through early diagnosis and optimized personalized medical services.
- Figures: None
- Case studies/anecdotes: None
About CDbio
CDbio is a pioneering digital asset management platform that converges traditional finance with the burgeoning realm of cryptocurrency, fostering a novel paradigm for investors seeking to navigate the complexities of the digital asset landscape.
CDBIO is a pioneering medical foundation headquartered in the Republic of Seychelles, specializing in the provision of cutting-edge molecular medical and healthcare services, rooted in the principles of advanced molecular physics.
The world’s pioneering commercial research collaborator, Yasama Yasuhiko (Yasama), CEO of Idea International and CTO of the CDBIO Foundation, is currently affiliated with the Tohoku University Research and Analytical Center for Giant Molecular Studies. His groundbreaking work on molecular sensors utilizing lithium-resistant fullerene has yielded exceptionally high-precision technologies, capable of facilitating the flow of a single electron per molecule. This innovation enables the diagnosis of diseases and monitoring of health conditions in response to medication effects. This cutting-edge medical technology has the potential to revolutionize healthcare by providing customized prescriptions and treatments tailored to individual patient characteristics. Building upon this technology, CDBIO is developing the Molecular Medical & Healthcare Platform, a blockchain-based ecosystem that converges the expertise of global molecular physics and electrochemical scholars with the collective intelligence of professional medical communities and patient networks. This molecular-medical/healthcare platform aims to overcome diseases through early diagnosis and provision of optimized, personalized medical services to individual patients, ultimately contributing to human health and longevity through disease prevention and systematic healthcare.